These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31585024)

  • 1. Positional effects of premature termination codons on the biochemical and biophysical properties of CFTR.
    Yeh JT; Hwang TC
    J Physiol; 2020 Feb; 598(3):517-541. PubMed ID: 31585024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations.
    Mutyam V; Sharma J; Li Y; Peng N; Chen J; Tang LP; Falk Libby E; Singh AK; Conrath K; Rowe SM
    Am J Respir Cell Mol Biol; 2021 May; 64(5):604-616. PubMed ID: 33616476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Responses of the G542X-CFTR to CFTR Modulators.
    Fang X; Yeh JT; Hwang TC
    Front Mol Biosci; 2022; 9():921680. PubMed ID: 35813815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor.
    Xue X; Mutyam V; Tang L; Biswas S; Du M; Jackson LA; Dai Y; Belakhov V; Shalev M; Chen F; Schacht J; J Bridges R; Baasov T; Hong J; Bedwell DM; Rowe SM
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):805-16. PubMed ID: 24251786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences.
    Xue X; Mutyam V; Thakerar A; Mobley J; Bridges RJ; Rowe SM; Keeling KM; Bedwell DM
    Hum Mol Genet; 2017 Aug; 26(16):3116-3129. PubMed ID: 28575328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.
    Yeh JT; Yu YC; Hwang TC
    J Physiol; 2019 Jan; 597(2):543-560. PubMed ID: 30408177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of premature termination codon mutations on CFTR mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read-through therapies in cystic fibrosis.
    Clarke LA; Awatade NT; Felício VM; Silva IA; Calucho M; Pereira L; Azevedo P; Cavaco J; Barreto C; Bertuzzo C; Gartner S; Beekman J; Amaral MD
    Hum Mutat; 2019 Mar; 40(3):326-334. PubMed ID: 30488522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators.
    Chen J; Thrasher K; Fu L; Wang W; Aghamohammadzadeh S; Wen H; Tang L; Keeling KM; Falk Libby E; Bedwell DM; Rowe SM
    Am J Physiol Lung Cell Mol Physiol; 2023 Jun; 324(6):L756-L770. PubMed ID: 37014818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids.
    Zomer-van Ommen DD; Vijftigschild LA; Kruisselbrink E; Vonk AM; Dekkers JF; Janssens HM; de Winter-de Groot KM; van der Ent CK; Beekman JM
    J Cyst Fibros; 2016 Mar; 15(2):158-62. PubMed ID: 26255232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough.
    Lee RE; Lewis CA; He L; Bulik-Sullivan EC; Gallant SC; Mascenik TM; Dang H; Cholon DM; Gentzsch M; Morton LC; Minges JT; Theile JW; Castle NA; Knowles MR; Kimple AJ; Randell SH
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLN468 changes the pattern of tRNA used to read through premature termination codons in CFTR.
    Karri S; Cornu D; Serot C; Biri L; Hatton A; Dréanot E; Rullaud C; Pranke I; Sermet-Gaudelus I; Hinzpeter A; Bidou L; Namy O
    J Cyst Fibros; 2024 Nov; 23(6):1185-1194. PubMed ID: 39098506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readthrough-induced misincorporated amino acid ratios guide mutant-specific therapeutic approaches for two CFTR nonsense mutations.
    Premchandar A; Ming R; Baiad A; Da Fonte DF; Xu H; Faubert D; Veit G; Lukacs GL
    Front Pharmacol; 2024; 15():1389586. PubMed ID: 38725656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating REPAIRv2 as a Tool to Edit
    Melfi R; Cancemi P; Chiavetta R; Barra V; Lentini L; Di Leonardo A
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids.
    de Poel E; Spelier S; Suen SWF; Kruisselbrink E; Graeber SY; Mall MA; Weersink EJM; van der Eerden MM; Koppelman GH; van der Ent CK; Beekman JM
    J Cyst Fibros; 2022 Mar; 21(2):246-253. PubMed ID: 34666947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54.
    Rowe SM; Sloane P; Tang LP; Backer K; Mazur M; Buckley-Lanier J; Nudelman I; Belakhov V; Bebok Z; Schwiebert E; Baasov T; Bedwell DM
    J Mol Med (Berl); 2011 Nov; 89(11):1149-61. PubMed ID: 21779978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel G542X CFTR Rat Model of Cystic Fibrosis Is Sensitive to Nonsense Mediated Decay.
    Sharma J; Abbott J; Klaskala L; Zhao G; Birket SE; Rowe SM
    Front Physiol; 2020; 11():611294. PubMed ID: 33391025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations.
    Liang F; Shang H; Jordan NJ; Wong E; Mercadante D; Saltz J; Mahiou J; Bihler HJ; Mense M
    SLAS Technol; 2017 Jun; 22(3):315-324. PubMed ID: 28376702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrity and Stability of PTC Bearing CFTR mRNA and Relevance to Future Modulator Therapies in Cystic Fibrosis.
    Clarke LA; Luz VCC; Targowski S; Ramalho SS; Farinha CM; Amaral MD
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids.
    Crawford DK; Mullenders J; Pott J; Boj SF; Landskroner-Eiger S; Goddeeris MM
    J Cyst Fibros; 2021 May; 20(3):436-442. PubMed ID: 33558100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.